Commentary: Biotechnology lets scientists engineer natural ingredients into products, often more sustainably than if they were farmed. Here's what to know. Deenie is a CNET Voices contributor ...

Venture mega-rounds are on the rise in biotechnology as the outlook for the industry brightens. Sixty-eight U.S. and European biotech startups raised venture financings of $100 million or more ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

So if you're looking to make a relatively small investment of $1,000 in one stock that's on the riskier side, it's hard to park your cash in a more exciting and upwardly mobile biotech than Viking.

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

ARCH Venture Partners has raised $3 billion for a new fund — one of the largest in the biotech industry, and one the VC firm will use to continue its contrarian investment strategy.

An investment in these players today could score a big win down the road. Why do investors love biotech stocks? Because these players often work on game-changing technology that could lead to ...

The pharma told Fierce Biotech at the time that the reorganization would impact “a limited number” of employees, against a backdrop of various downsizing rounds at Genentech over the past year.

Call it a case of good chemistry: Acepodia, a biotech based on Nobel Prize-winning science, is entering into a new partnership with Pfizer’s Ignite program to support development of the biotech ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

However, many question whether this is a healthy or sustainable approach for either party, leading to many questions: What has been the true impact of M&amp,A on the biotech space? How has the ...

Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar rating. The primary contributor to the rating is its parent firm's superior long-term risk-adjusted performance ...